Contemporary Drug Problems is open to any research paper that contributes to social, cultural, historical or epidemiological knowledge and theory concerning drug use and related problems. All submissions to the journal, regardless of method or disciplinary approach, should be consistent with the general insight that drug use, drug effects and drug-related problems are shaped by social, cultural, political, historical, legal and economic contexts. Contemporary Drug Problems also recognizes that innovative or challenging research can sometimes struggle to find a suitable outlet. The journal therefore particularly welcomes original studies for which publication options are limited, including historical research, qualitative studies, and policy and legal analyses.
To determine the suitability of a manuscript for submission, prospective authors should first review the aims and scope of the journal and past issues. If you remain unsure if your manuscript would be suitable for the journal, please email Kate Seear and kylie valentine (K.Seear@latrobe.edu.au; email@example.com)
Contemporary Drug Problems is a scholarly journal that publishes peer-reviewed social science research on alcohol and other psychoactive drugs, licit and illicit. The journal’s orientation is multidisciplinary and international; it is open to any research paper that contributes to social, cultural, historical or epidemiological knowledge and theory concerning drug use and related problems. All submissions to the journal, regardless of method or disciplinary approach, should be consistent with the general insight that drug use, drug effects and drug-related problems are shaped by social, cultural, political, historical, legal and economic contexts. While Contemporary Drug Problems publishes all types of social science research on alcohol and other drugs, it recognizes that innovative or challenging research can sometimes struggle to find a suitable outlet. The journal therefore particularly welcomes original studies for which publication options are limited, including historical research, qualitative studies, and policy and legal analyses. In terms of readership, Contemporary Drug Problems serves a burgeoning constituency of social researchers as well as policy makers and practitioners working in health, welfare, social services, public policy, criminal justice and law enforcement.
|Kate Seear||Australian Research Centre in Sex, Health and Society, La Trobe University, Australia|
|kylie valentine||University of New South Wales, Australia|
|David Moore||Australian Research Centre in Sex, Health and Society, La Trobe University, Australia|
|Suzanne Fraser||Australian Research Centre in Sex, Health and Society, La Trobe University, Australia|
|Kim Bloomfield||Aarhus University, Denmark|
|Nancy Campbell||Department of Science and Technology Studies, Rensselaer Polytechnic Institute, USA|
|Mats Ekendahl||Department of Social Work, Stockholm University, Sweden|
|Marie Jauffret-Roustide||CERMES 3, French National Institute of Health and Medical Research, France|
|Michael Savic||Monash University, Australia|
|Mark Stoové||Behaviours and Health Risks Program, Burnet Institute, Australia|
|Campbell Aitken||Burnet Institute, Australia|
|Rosa Alati||University of Queensland, Australia|
|Virginia Berridge||London School of Hygiene and Tropical Medicine, UK|
|Philippe Bourgois||University of California, Los Angeles, USA|
|Jade Boyd||University of British Columbia, Canada|
|Ross Coomber||University of Liverpool, UK|
|Fay Dennis||Goldsmiths, University of London, UK|
|Cameron Duff||RMIT University, Australia|
|Tristan Duncan||Monash University, Australia|
|Robyn Dwyer||La Trobe University, Australia|
|Adrian Farrugia||La Trobe University, Australia|
|Benedikt Fischer||Simon Fraser University, Canada|
|Renae Fomiatti||Deakin University, Australia|
|Kate Graham||Centre for Addiction and Mental Health, Canada|
|Jean-Paul Grund||University of Utrecht, Netherlands|
|Philip Hadfield||University of Leeds, UK|
|Maria Herold||Aarhus University, Denmark|
|Marja Holmila||National Institute for Health and Welfare, Finland|
|Geoffrey Hunt||Institute for Scientific Analysis, USA|
|Fiona Hutton||Victoria University of Wellington, New Zealand|
|Helen Keane||Australian National University, Australia|
|William Kerr||Alcohol Research Group, USA|
|Jo Kimber||Kings College London, UK|
|Stuart Kinner||University of Melbourne, Australia|
|Ludwig Kraus||Institute for Therapy Research, Germany|
|Karen Joe Laidler||The University of Hong Kong, Hong Kong, China|
|J.R. Latham||Deakin University, Australia|
|Scott Macdonald||University of Victoria, Canada|
|Robert Mann||Centre for Addiction and Mental Health, Canada|
|Rebecca McKetin||University of New South Wales, Australia|
|Fiona Measham||University of Liverpool, UK|
|Jane Mounteney||European Monitoring Centre for Drugs and Drug Addiction, Portugal|
|Kiran Pienaar||Deakin University, Australia|
|Kane Race||University of Sydney, Australia|
|Mats Ramstedt||Karolinska Institute, Sweden|
|Craig Reinarman||University of California, Santa Cruz, USA|
|Tim Rhodes||London School of Hygiene and Tropical Medicine, UK|
|Robin Room||La Trobe University, Australia|
|Laura Schmidt||University of California, San Francisco, USA|
|Trang N. Thu||Hanoi Medical University, Vietnam|
|Shelley Walker||Burnet Institute, Australia|
This Journal is a member of the Committee on Publication Ethics.
Contemporary Drug Problems recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit Contemporary Drug Problems’ submission site [https://mc.manuscriptcentral.com/cdx] to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Sage disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.
Only manuscripts of sufficient quality that meet the aims and scope of Contemporary Drug Problems will be reviewed.
There are no fees payable to submit or publish in this Journal.
As part of the submission process, you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in Contemporary Drug Problems and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that Contemporary Drug Problems will consider submissions of papers that have been posted on preprint servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper to a preprint server while it is being peer reviewed for possible publication in Contemporary Drug Problems. If your paper is accepted, you will need to contact the preprint server to ensure the final published article link is attached to your preprint. Learn more about our preprint policy here.
If you have any questions about publishing with Sage, please visit the Sage Journal Solutions Portal.
1.1 Aims & Scope
1.2 Article types
2.7 Research data
4.5 Reference style
6.1 Sage Production
1.1 Aims & Scope
Before submitting your manuscript to Contemporary Drug Problems, please ensure you have read the Aims & Scope.
1.2 Article types
While Contemporary Drug Problems publishes all types of social science research on alcohol and other drugs, it recognizes that innovative or challenging research can sometimes struggle to find a suitable outlet. The journal therefore particularly welcomes original studies for which publication options are limited, including historical research, qualitative studies, and policy and legal analyses.
1.3 Writing your paper
Visit the Sage Author Gateway for general advice on how to get published, plus links to further resources.
Sage Author Services also offers authors a variety of ways to improve and enhance your article including English language editing, plagiarism detection, and video abstract and infographic preparation.
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online.
2.1 Peer review policy
Sage does not permit the use of author-suggested (recommended) reviewers at any stage of the submission process, be that through the web-based submission system or other communication.
Reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Our policy is that reviewers should not be assigned to a paper if:
- The reviewer is based at the same institution as any of the co-authors.
- The reviewer is based at the funding body of the paper.
- The author has recommended the reviewer.
- The reviewer has provided a personal (e.g. Gmail/Yahoo/Hotmail) email account and an institutional email account cannot be found after performing a basic Google search (name, department and institution).
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Contemporary Drug Problems utilizes a double-anonymized peer review process in which the reviewer and authors’ names and information are withheld from the other. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in Contemporary Drug Problems. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.
Special issue manuscripts are sent to Guest Editors upon submission to ensure they meet the scope of the special issue. The rest of the peer review process will be handled by Contemporary Drug Problems' internal editorial team. Reviewers make comments to the author and recommendations to the Editor who then makes the final decision.
Contemporary Drug Problems is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Web of Science (previously Publons). Web of Science is a third-party service that seeks to track, verify and give credit for peer review. Reviewers for Contemporary Drug Problems can opt in to Web of Science in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Web of Science website.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Please supply any personal acknowledgements separately to the main text to facilitate anonymous peer review.
Per ICMJE recommendations, it is best practice to obtain consent from non-author contributors who you are acknowledging in your paper.
2.3.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, Sage reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.3.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
2.4 Declaration of conflicting interests
It is the policy of Contemporary Drug Problems to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgments and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please review the good practice guidelines on the Sage Journal Author Gateway and see the ICMJE recommendations here.
Contemporary Drug Problems requires all authors to acknowledge their funding when submitting their manuscripts. Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway for more information on Funding Acknowledgements.
2.6 Research ethics and patient consent
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
2.7 Research data
Contemporary Drug Problems is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- Share your research data in a relevant public data repository
- Include a data availability statement linking to your data. If it is not possible to share your data, use the statement to confirm why it cannot be shared.
- Cite this data in your research
If you need to anonymize your research data for peer review, please refer to our Research Data Sharing FAQs for guidance.
3.1 Publication ethics
Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the Sage Author Gateway.
Contemporary Drug Problems and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of Contemporary Drug Problems against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.
3.2 Contributor’s publishing agreement
Before publication, Sage requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information, please visit the Sage Author Gateway.
3.3 Open access and author archiving
Contemporary Drug Problems offers optional open access publishing via the Sage Choice program. For more information on Open Access publishing options at Sage please visit Sage Open Access. For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.
- All manuscripts (including abstract, quotations, references, and endnotes) should be double-spaced and submitted as an MS Word (.doc & .docx) file.
- Tables and figures should appear at the end of the manuscript – each on a separate page – and their location in the text indicated with a callout: "(Table/Figure 1)."
- Please use MS Word’s tools to create editable tables, charts, and graphs when possible.
- Other images should be submitted as high-resolution (300 dpi) TIFF, JPEG, or EPS individual files. Please do not embed images within the document, as this reduces their overall quality.
- While there is no word limit on manuscripts, authors should include a justification if their manuscript exceeds 10,000 words (excluding references).
- Submissions are assessed by the Editor to ensure that they are consistent with the aims and scope of the journal, and are suitable for peer review. Submissions that proceed to peer review are assigned to an Associate Editor, who obtains assessments from at least two researchers expert in the areas covered by the submission and provides a recommendation to the Editor. The Editor considers the comments of the reviewers and the recommendation of the Associate Editor, and communicates the decision to the authors.
To allow for double-anonymized reviewing, the cover page should be submitted separately and should include:
- the title of the manuscript and the names and affiliations of all authors, as well as the contact details for the corresponding author
- a brief biographical sketch for each author
- acknowledgments (where relevant) and declarations of conflicting interest as well as funding information.
- The main text should be submitted as a separate document and should include the manuscript title, an abstract of 150-300 words and up to six keywords for indexing.
- Please remove all identifying details from the main text (e.g., publications by the submitting author(s) where these allow for identification).
Specific Style Points
Headings and Subheadings
Subheadings should indicate the organization of the content of the manuscript. Generally, three heading levels should be sufficient to organize the text.
1st level: Flush left, boldface, upper and lowercase
2nd level: Flush left, boldface, italicized, upper and lowercase
3rd level: Flush left, italicized, upper and lowercase
Please use U.S. English spelling. The terms amongst, whilst, towards are among, while, toward in U.S. English.
- Use a serial (Oxford) comma in lists of three or more items (i.e., apples, pears, and lemons).
- Do not hyphenate most words formed with commonly used prefixes (e.g., semistructured, nondenominational, multimedia, antisocial, posttest, pretest, socioeconomic). Exceptions are words that could be misunderstood (e.g., re-create, re-form [to form again]) and words in which a vowel is repeated (e.g., anti-intellectual).
- The first word after a colon is capitalized if the text following it is a complete sentence, otherwise it is lowercased.
- Do not capitalize the names of theories, models, conditions, or diseases.
- Capitalize the first word of a direct quotation if the quoted text is a complete sentence, otherwise begin the quote with a lowercase letter.
- Retain the original spelling and punctuation within a direct quotation. Insert any altered text or insert "[sic]" within brackets.
- Use ellipses (…) only in the middle of a quotation, not at the beginning or end.
- Place periods and commas at the end of quotations inside the quotation marks.
- Include the page number of the quotation in parentheses immediately following, for example, "(Abbott et al., 1997, p. 208)."
Items in a List
Within a paragraph, list items that must appear in a certain order as (a), (b), and (c). If the order is unimportant, then remove the letters. Use vertical lists when expressing information that must appear in a certain order (e.g., steps in a procedure or itemized conclusions).
Numbers 10 and higher should appear as arabic numerals (e.g., 1, 2, 3). Data indicating time, age, distance, ratios, and percentages should always appear as arabic numerals unless at the start of a sentence.
Use the Latin abbreviations e.g., i.e., etc. only within parentheses. In the text of the sentence, use the abbreviation’s English translation (for instance/example, that is/in other words, and so on).
4.2 Artwork, figures and other graphics
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit Sage’s Manuscript Submission Guidelines.
Figures supplied in color will appear in color online regardless of whether or not these illustrations are reproduced in color in the printed version. For specifically requested color reproduction in print, you will receive information regarding the costs from Sage after receipt of your accepted article.
4.3 Identifiable information
Where a journal uses double-anonymized peer review, authors are required to submit:
- A version of the manuscript which has had any information that compromises the anonymity of the author(s) removed or anonymized. This version will be sent to the peer reviewers.
- A separate title page which includes any removed or anonymized material. This will not be sent to the peer reviewers.
See section 4.1 for more information on preparing your manuscript for double-anonymized peer review.
4.4 Supplemental material
Contemporary Drug Problems is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
4.5 Reference style
Contemporary Drug Problems adheres to the APA reference style. View the APA guidelines to ensure your manuscript conforms to this reference style.
For every reference, there should be a corresponding citation and vice-versa. Each corresponding citation should have identical spelling and year of publication. The use of DOIs is encouraged to improve accessibility.
- Edman, J. (2012). Swedish drug treatment and the political use of conceptual innovation 1882-1982. Contemporary Drug Problems, 39, 429–461.
- Coomber, R. (1997). Using the Internet for survey research. Sociological Research Online, 2. Retrieved January 10, 2014, from www.socresonline.org.uk
- Carr, E. S. (2011). Scripting addiction: The politics of therapeutic talk and American sobriety. Princeton, NJ: Princeton University Press.
- Bunton, R., Nettleton, S., & Burrows, R. (Eds.). (1995). The sociology of health promotion: Critical analyses of consumption, lifestyle and risk. London: Routledge.
- Charmaz, K. (2000). Grounded theory: Objectivist and constructivist methods. In N. Denzin & Y. Lincoln (Eds.), Handbook of qualitative research (2nd ed., pp. 509–535). Thousand Oaks, CA: Sage.
4.6 English language editing services
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit Contemporary Drug Problems’s specifications should consider using Sage Language Services. Visit Sage Language Services on our Journal Author Gateway for further information.
5. Submitting your manuscript
Contemporary Drug Problems is hosted on Sage Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit [https://mc.manuscriptcentral.com/cdx] to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for Contemporary Drug Problems in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this Journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
5.2 Information required for completing your submission
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the Sage Author Gateway.
6.1 Sage Production
Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal Sage Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.
6.2 Online First publication
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the Sage Journals help page for more details, including how to cite Online First articles.
6.3 Access to your published article
6.4 Promoting your article
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
7. Further information
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Contemporary Drug Problems editorial office as follows:
Kate Seear and kylie valentine, Editors
7.1 Appealing the publication decision
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at firstname.lastname@example.org